|
|

楼主 |
发表于 2025-5-3 20:37:44
|
显示全部楼层
本帖最后由 NatureBoy 于 2025-5-3 20:41 编辑 & d; o% e: O8 s5 o3 `
' J" ^% x% J4 w- y* }! U! E今年ASCO大会,肿瘤内科三大BU——头颈肿瘤、胸部肿瘤、腹部肿瘤中表现相对好的是头颈肿瘤BU,腹部肿瘤和生物治疗科今年哑火了
2 Y( t$ C, a7 O! j0 y
6 v7 H S5 O" M t! Q* s% h头颈肿瘤BU入选ASCO 2025的研究
/ ~2 c! J$ M5 B% k/ u, \( yHot flashes and night sweats in women with breast cancer: Prevalence and severity of symptoms.
' m& Q0 H* r8 A8 H7 E" p1 h肿瘤内科-头颈肿瘤科姜愚团队
6 u) @" c9 v1 `
: \2 U- V: O( p/ i! QNeoadjuvant immunotherapy in combination with chemotherapy in resectable locally advanced head and neck squamous cell carcinoma: A randomized, open label, phase II clinical trial.$ E6 R& J: U. i; Z4 C( A. N
肿瘤内科-头颈肿瘤科刘磊团队" k7 R6 a+ L/ S" a# j- C
- |6 @8 C' _: l+ }* j1 C( u
A phase II study of AK117 combined with cetuximab or AK104 in the treatment of recurrent or metastatic head and neck squamous cell carcinoma after the failure of PD-1 (L1) inhibitors and/or platinum-based therapy.: g. t- N4 I0 O1 U! @
肿瘤内科-头颈肿瘤科刘磊团队
) m- G0 ^$ h; O$ S! ~( o3 b" O6 ]- V
A phase II randomized trial of nano-crystalline megestrol acetate for nutritional improvement in postoperative head and neck squamous cell carcinoma undergoing radiotherapy.
2 A# E5 c1 \5 t6 [! D b肿瘤内科-头颈肿瘤科刘磊团队# C2 ^0 ^* g0 p# b8 }2 [' V! O5 t
& |9 r+ D: e$ K9 S: N
ribulin plus anlotinib in advanced soft tissue sarcoma (ERAS): Updates on efficacy and biomarkers.
1 A' I( Y. k6 _# t4 ^肿瘤内科-头颈肿瘤科姜愚团队
! `1 e, e0 H( L" [' q2 w |
|